Theravance Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Winningham Rick E
Theravance Biopharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Weiss Asset Management LP BIP GP LLC WAM GP LLC Andrew M. Weiss Ph.D.(Weiss Asset Management LP 15.5%)
Theravance Biopharma | 10-K: Annual report
Theravance Biopharma | 8-K: Current report
Theravance Biopharma | 8-K: Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Theravance Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Winningham Rick E
Theravance Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Sawaf Aziz
Theravance Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Miller Aine
Theravance Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Grimaud Brett A.
Theravance Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer GRAHAM RICHARD A
Theravance Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Farnum Rhonda
Theravance Biopharma | 3: Initial statement of beneficial ownership of securities-Officer Miller Aine
Theravance Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Irenic Capital Management LP(5.5%),Irenic Capital Evergreen Master Fund LP(5.5%), etc.
Theravance Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(7.01%)
Theravance Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(9.2%)
Theravance Biopharma | 8-K: Current report
Theravance Biopharma | 8-K: Current report
Theravance Biopharma | 8-K: Current report
Theravance Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Grant Jeremy T
Theravance Biopharma | 3: Initial statement of beneficial ownership of securities-Director Grant Jeremy T
No Data